| Heme-oxygenase-1: A potential biomarker for ICIs in patients with advanced lung cancer. F Biello, V Martini, G Borra, S Genestroni, C Branni, J Gennari, I Duka, ... Journal of Clinical Oncology 42 (16_suppl), e20505-e20505, 2024 | | 2024 |
| Specialization determines outcomes in inflammation and cancer A Sica, M Lazzeri nature immunology 24 (9), 1399-1401, 2023 | | 2023 |
| Cancer immunity and immunotherapy beyond COVID-19 M Bellone, A Brevi, V Bronte, S Dusi, PF Ferrucci, P Nisticò, A Rosato, ... Cancer Immunology, Immunotherapy 72 (7), 2541-2548, 2023 | | 2023 |
| Efficacy and safety of nilotinib as frontline treatment in elderly (> 65 years) chronic myeloid leukemia patients outside clinical trials L Luciano, R Latagliata, G Gugliotta, M Annunziata, M Tiribelli, B Martino, ... Annals of Hematology 102 (6), 1375-1382, 2023 | 4 | 2023 |
| Inflammaging and osteoarthritis F Motta, E Barone, A Sica, C Selmi Clinical Reviews in Allergy & Immunology 64 (2), 222-238, 2023 | 111 | 2023 |
| Immunometabolic interference between cancer and COVID-19 FM Consonni, B Durante, M Manfredi, A Bleve, C Pandolfo, V Garlatti, ... Frontiers in Immunology 14, 1168455, 2023 | 3 | 2023 |
| Inflammaging and Osteoarthritis. A Sica Clinical Reviews in Allergy & Immunology, 2023 | | 2023 |
| RORγ bridges cancer-driven lipid dysmetabolism and myeloid immunosuppression A Bleve, FM Consonni, M Incerti, V Garlatti, C Pandolfo, MN Monari, ... bioRxiv, 2023.11. 19.567414, 2023 | | 2023 |
| Circulating fatty acid profile as a biomarker for immunotherapy in advanced non-small cell lung cancer G Galli, PA Corsetto, C Proto, GL Russo, M Ganzinelli, E Rulli, ... Clinical Lung Cancer 23 (7), e489-e499, 2022 | 4 | 2022 |
| Precision medicine approaches with metabolomics and artificial intelligence E Barberis, S Khoso, A Sica, M Falasca, A Gennari, F Dondero, A Afantitis, ... International Journal of Molecular Sciences 23 (19), 11269, 2022 | 14 | 2022 |
| Cancer bio-immunotherapy XVIII annual NIBIT-(Italian network for tumor biotherapy) meeting, October 15–16, 2020 M Bellone, A Brevi, V Bronte, S Dusi, PF Ferrucci, P Nisticò, A Rosato, ... Cancer Immunology, Immunotherapy, 1-8, 2022 | | 2022 |
| Cancer bio-immunotherapy XVII annual NIBIT (Italian Network for Tumor Biotherapy) meeting, October 11–13 2019, Verona, Italy M Bellone, M Bregni, V Bronte, S Ugel, PF Ferrucci, M Di Nicola, P Nisticò, ... Cancer Immunology, Immunotherapy, 1-10, 2022 | | 2022 |
| AB0050 ALTERED NAMPT, ADIPOKINE AND CYTOKINE LEVELS CHARACTERIZE MONOCYTE ACTIVITY AND CORRELATE WITH DISEASE SEVERITY IN OSTEOARTHRITIS F Motta, B Durante, C Pandolfo, C Selmi, A Sica Annals of the Rheumatic Diseases 81 (Suppl 1), 1159-1160, 2022 | | 2022 |
| 21P Metabolomic profiling and response to neoadjuvant therapy in operable breast cancer A Gennari, V Martini, R Boldorini, C Saggia, V Rossi, F D'Avanzo, ... Annals of Oncology 33, S132, 2022 | | 2022 |
| Prolonged exposure to simulated microgravity promotes stemness impairing morphological, metabolic and migratory profile of pancreatic cancer cells: A comprehensive proteomic … MA Masini, V Bonetto, M Manfredi, A Pastò, E Barberis, S Timo, ... Cellular and Molecular Life Sciences 79 (5), 226, 2022 | 7 | 2022 |
| Evolution and targeting of myeloid suppressor cells in cancer: a translational perspective A Bleve, FM Consonni, C Porta, V Garlatti, A Sica Cancers 14 (3), 510, 2022 | 11 | 2022 |
| Immunosenescence, inflammaging, and frailty: role of myeloid cells in age-related diseases A Bleve, F Motta, B Durante, C Pandolfo, C Selmi, A Sica Clinical reviews in allergy & immunology, 1-22, 2022 | 64 | 2022 |
| 1777P HEME catabolism in peripheral monocytes and response to immune checkpoint inhibitors in advanced lung cancer F Biello, V Martini, C Branni, G Borra, S Genestroni, A Mennitto, C Cattrini, ... Annals of Oncology 32, S1218, 2021 | | 2021 |
| Heme catabolism by tumor-associated macrophages controls metastasis formation FM Consonni, A Bleve, MG Totaro, M Storto, P Kunderfranco, A Termanini, ... Nature immunology 22 (5), 595-606, 2021 | 66 | 2021 |
| Implications of metabolism-driven myeloid dysfunctions in cancer therapy L Strauss, V Guarneri, A Gennari, A Sica Cellular & molecular immunology 18 (4), 829-841, 2021 | 25 | 2021 |
